Clinical Trials Sponsored by The First Hospital of Tonglu County, Hangzhou

Total 1071 results

The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Anti-PD-1/PD-L1 Antibody Plus Apatinib as Second-Line Treatment of Advanced Esophageal Squamous Cell

Esophageal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Completed

Genetic Research on High Myopic Individuals in Northern China

High Myopia

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Botulinum Toxin for Trigeminal Neuralgia (EASTERN)

Trigeminal Neuralgia

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis

Clinical Pregnancy Rate

China
The First Affiliated Hospital of Zhengzhou University

Completed

Aminophylline for Patients With Post-Dural Puncture Headache

Post-dural Puncture Headache

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Esophageal Squamous Cell Carcinoma (ESCC) | PD-1 Inhibitors

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

Capecitabine | MSI-H Colorectal Cancer | Oxaliplatin | Tislelizumab
The First Affiliated Hospital of Zhengzhou University

Recruiting

Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

Malignant Pleural Effusion
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Esophageal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Resectable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Recruiting

Newborns From Patients Treated With ART (Assisted Reproductive Technology)

Health Related

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Active, not recruiting

Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC)

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Application of a New Ovarian Stimulation Protocol in IVF

Ovulation Induction | Clinical Pregnancy Rate

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis

Vertebral Artery Stenosis

China
The First Affiliated Hospital of Zhengzhou University

Unknown

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

Hepatocellular Carcinoma
The First Affiliated Hospital of Zhengzhou University

Unknown

Effect of Endometrial Thickness on IVF Outcome

Infertility

China
First Affiliated Hospital of Zhejiang University
The First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital... and other collaborators

Unknown

A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer

Liver Cancer
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Effects of iTBS Combined With NMES on Dysphagia After Stroke

Stroke | Dysphagia | Neuromuscular Electrical Stimulation | Intermittent Theta Burst Stimulation | Functional Near-infrared Spectroscopy
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer

Metastatic Colorectal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction

Brain Stem Infarctions | Dysphagia, Esophageal | Dysphagia, Oropharyngeal

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Mindfulness Yoga and Sexual Functioning

Breast Cancer | Sexual Dysfunction

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.

Colon Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

Breast Cancer | Breast Cancer Female

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Cervical Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Metastatic Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Recurrent Glioma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Primary Ovarian Insufficient Patients

Healthy Related

China
The First Affiliated Hospital of Zhengzhou University

Active, not recruiting

Tislelizumab in Addition to BACE in Patients With NSCLC

NSCLC

China
The First Affiliated Hospital of Zhengzhou University

Completed

Site Selection of Short Peripheral Venous Catheters (SPECIAL)

Short Peripheral Venous Catheter

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Advanced Esophageal Squamous Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Application of Time-lapse System in IVF/ICSI

the Application of Time-lapes System in IVF/ICSI

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Effectiveness of Endometrial Injury in IVF

Infertility

China
Wu Jun

Not yet recruiting

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Adenocarcinoma | Gastric Cancer | GastroEsophageal Cancer

China
Wu Jun

Recruiting

Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study

Gastric Cancer

China
People's Hospital of Zhengzhou University
The First Affiliated Hospital of Zhengzhou University

Withdrawn

Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease

Parkinson Disease

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

The Effect of Different Body Positions and Channel Sheaths on RIRS

Urolithiasis

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Effectiveness of Harmonica Playing in Improving Lung Function Among COPD Patients

COPD

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression

Non-small Cell Lung Cancer

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

The Effect of HFNC on Exercise Capacity Compared to VM in COPD Patients Recovering From Acute Evacerbation

COPD

China
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Mature Vinegar Prophylaxis Against Recurrent Calcium Oxalate Nephrolithiasis

Nephrolithiasis

China
The First Affiliated Hospital of Guangzhou Medical...

Completed

The Feasibility, Safety, and Efficacy of Not Indwelling of Ureteral Stents in Percutaneous Nephrolithotomy

Urolithiasis

China
The First Affiliated Hospital of Guangzhou Medical...

Completed

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19

Coronavirus Disease 2019 | Character of the Severe Patients

China
The First Affiliated Hospital of Guangzhou Medical...

Completed

The Relationship Between the Neural Drive and Intrinsic Positive End-expiratory Pressure

Chronic Obstructive Pulmonary Disease

China

Clinical Trials Sponsored by The First Hospital of Tonglu County, Hangzhou

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations